EXD2: A new regulator of mitochondrial translation and potential target for cancer therapy

被引:1
|
作者
Stracker, Travis H. [1 ]
机构
[1] BIST, Inst Res Biomed IRB Barcelona, Barcelona, Spain
来源
MOLECULAR & CELLULAR ONCOLOGY | 2018年 / 5卷 / 03期
关键词
EXD2; mitochondria; metabolic reprogramming; metformin; cancer metabolism; translation; glutamine; Biology of malignant cells; Cancer stem cells; Mode of action of anticancer agents; Tumor metabolism;
D O I
10.1080/23723556.2018.1445943
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In recent work we identified Exonuclease 3'-5' domain-containing protein 2 (EXD2) as an RNase required for efficient mitochondrial translation. Here I describe in brief the cellular phenotypes caused by EXD2 deficiency and make the case that EXD2 inhibitors could be valuable agents for cancer therapy.
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Exonuclease EXD2 in mitochondrial translation
    Brian M. Zid
    Pankaj Kapahi
    Nature Cell Biology, 2018, 20 : 120 - 122
  • [2] Exonuclease EXD2 in mitochondrial translation
    Zid, Brian M.
    Kapahi, Pankaj
    NATURE CELL BIOLOGY, 2018, 20 (02) : 120 - 122
  • [3] EXD2 governs germ stem cell homeostasis and lifespan by promoting mitoribosome integrity and translation
    Joana Silva
    Suvi Aivio
    Philip A. Knobel
    Laura J. Bailey
    Andreu Casali
    Maria Vinaixa
    Isabel Garcia-Cao
    Étienne Coyaud
    Alexis A. Jourdain
    Pablo Pérez-Ferreros
    Ana M. Rojas
    Albert Antolin-Fontes
    Sara Samino-Gené
    Brian Raught
    Acaimo González-Reyes
    Lluís Ribas de Pouplana
    Aidan J. Doherty
    Oscar Yanes
    Travis H. Stracker
    Nature Cell Biology, 2018, 20 : 162 - 174
  • [4] EXD2 governs germ stem cell homeostasis and lifespan by promoting mitoribosome integrity and translation
    Silva, Joana
    Aivio, Suvi
    Knobel, Philip A.
    Bailey, Laura J.
    Casali, Andreu
    Vinaixa, Maria
    Garcia-Cao, Isabel
    Coyaud, Etienne
    Jourdain, Alexis A.
    Perez-Ferreros, Pablo
    Rojas, Ana M.
    Antolin-Fontes, Albert
    Samino-Gene, Sara
    Raught, Brian
    Gonzalez-Reyes, Acaimo
    Ribas de Pouplana, Lluis
    Doherty, Aidan J.
    Yanes, Oscar
    Stracker, Travis H.
    NATURE CELL BIOLOGY, 2018, 20 (02) : 162 - +
  • [5] Mitochondrial uncoupling protein 2 and pancreatic cancer:A new potential target therapy
    Massimo Donadelli
    Ilaria Dando
    Elisa Dalla Pozza
    Marta Palmieri
    World Journal of Gastroenterology, 2015, (11) : 3232 - 3238
  • [6] Mitochondrial uncoupling protein 2 and pancreatic cancer: A new potential target therapy
    Donadelli, Massimo
    Dando, Ilaria
    Pozza, Elisa Dalla
    Palmieri, Marta
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (11) : 3232 - 3238
  • [7] Myofibrillogenesis regulator 1 as a potential target for cancer therapy
    Shao, R.
    Ren, K.
    Wang, Y.
    EJC SUPPLEMENTS, 2008, 6 (12): : 109 - 110
  • [8] The mitochondrial outer-membrane location of the EXD2 exonuclease contradicts its direct role in nuclear DNA repair
    Fenna Hensen
    Amandine Moretton
    Selma van Esveld
    Géraldine Farge
    Johannes N. Spelbrink
    Scientific Reports, 8
  • [9] The mitochondrial outer-membrane location of the EXD2 exonuclease contradicts its direct role in nuclear DNA repair
    Hensen, Fenna
    Moretton, Amandine
    van Esveld, Selma
    Farge, Geraldine
    Spelbrink, Johannes N.
    SCIENTIFIC REPORTS, 2018, 8
  • [10] Mitochondrial Peroxiredoxin III is a Potential Target for Cancer Therapy
    Song, In-Sung
    Kim, Hyoung-Kyu
    Jeong, Seung-Hun
    Lee, Sung-Ryul
    Kim, Nari
    Rhee, Byoung Doo
    Ko, Kyung Soo
    Han, Jin
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2011, 12 (10): : 7163 - 7185